| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 1.0K | 1.0% |
| Total Income | 1.1K | 0.6% |
| Expenditure | 915.60 | 13.3% |
| PBT | 167.90 | 399.7% |
| Net Profit | 143.30 | 319.0% |
| OPM | 16.32% | 18.01pp |
| NPM | 13.23% | 10.09pp |
| EPS | 31.88 | 318.9% |
Bayer CropScience Reports Q4 & Annual Results for FY 2024-25: Revenue from Operations of ¥54,734 million and Profit Before Tax of ¥37,074 million
26 May 2025 · 26 May 2025, 07:02 pm
Summary
Bayer CropScience Limited announced its results for the financial year and quarter ended March 31, 2025. The company's Revenue from Operations increased to ¥54,734 million in FY 2024-25, compared to ¥51,062 million in the previous year. Profit Before Tax stood at ¥7,074 million, compared to ¥9,414 million in the previous year. In Q4 of FY 2024-25, the Company registered Revenue from Operations of ¥10,464 million, compared to ¥7,923 million in the corresponding quarter of the previous year. Profit Before Tax for the quarter stood at €1,679 million, compared to ¥1,054 million in the corresponding quarter of the previous year.
Key Highlights
- 1
Revenue from Operations in FY 2024-25: ¥54,734 million
- 2
Profit Before Tax in FY 2024-25: ¥7,074 million
- 3
Q4 2024-25: Revenue from Operations: ¥10,464 million
- 4
Q4 2024-25: Profit Before Tax: €1,679 million
- 5
7% increase in Revenue from Operations for the full year
Management Comments
Simon Wiebusch
Vice Chairman, Managing Director and CEO, BCSL
In Q4, our Revenue from Operations grew by 32 percent over the previous year, driven by strong performance in spring corn and by both strong performance and double-digit liquidation growth in the crop protection portfolio. The promotional investments made in the previous quarter generated significant returns. Quarter-on-quarter deviations reflect the realities of our agriculture. Our focus on liquidation-led channel management aligns with market realities and demonstrates our commitment to delivering continuous value.
Vinit Jindal
Executive Director and Chief Financial Officer, BCSL
Our Revenue from Operations grew by 7 percent for the full year, demonstrating our resilience amid challenges like unpredictable monsoons and competitive pressures. Despite strict cost management, higher input costs, provisions for doubtful receivables, and continued investments to expand Bayer’s reach among farmers, influenced our bottom line. Strategic investments drove operating costs. Moving forward, we will maintain focus on these initiatives and adapt our strategies to meet evolving market and stakeholder needs.
Informational and educational content only. Not investment advice.